[關(guān)鍵詞]
[摘要]
中樞性卒中后疼痛是一種腦血管意外發(fā)生后的神經(jīng)病理性疼痛綜合征,臨床表現(xiàn)為肌肉骨骼疼痛、感覺(jué)異?;蚱渌杏X(jué)障礙等,并且疼痛部位與腦血管病變損傷的大腦區(qū)域相對(duì)應(yīng)。目前臨床上對(duì)中樞性卒中后疼痛的治療包括藥物、非藥物治療。中樞性卒中后疼痛的治療藥物主要包括抗抑郁藥、抗癲癇藥、阿片類藥物和麻醉藥等。就治療中樞性卒中后疼痛的藥物進(jìn)行綜述。
[Key word]
[Abstract]
Central post-stroke pain is a neuropathic pain syndrome after cerebrovascular accident. Clinical manifestations are muscle, bone pain, sensory abnormalities or other sensory disorders, and the pain site corresponds to the brain area of cerebrovascular disease. At present, the clinical treatment of central post-stroke pain includes drug and non-drug treatment. The treatment drugs for CPSP mainly include antidepressants, antiepileptics, opioids and anesthetics, etc. This article reviews progress in drug therapy for central post-stroke pain.
[中圖分類號(hào)]
R971
[基金項(xiàng)目]
廣西科技計(jì)劃項(xiàng)目(桂科AD20238028);廣西醫(yī)療衛(wèi)生事宜技術(shù)開(kāi)發(fā)與推廣應(yīng)用項(xiàng)目(S2020050);廣西高等學(xué)校高水平創(chuàng)新團(tuán)隊(duì)及卓越學(xué)者計(jì)劃[桂教人才(2020)6號(hào)];廣西中醫(yī)藥大學(xué)“岐黃工程”高層次人才團(tuán)隊(duì)培育項(xiàng)目(2018003);廣西中醫(yī)藥大學(xué)第一附屬醫(yī)院學(xué)術(shù)團(tuán)隊(duì)建設(shè)項(xiàng)目(院字[2018]146號(hào));廣西中醫(yī)藥大學(xué)2020年校級(jí)一般-碩士研究生科研創(chuàng)新項(xiàng)目(YCSY2020052)